Thalidomide for the nephrologist

Comment

Hassane Izzedine et al. Nephrol Dial Transplant. 2005 Sep.

. 2005 Sep;20(9):2011-2.

doi: 10.1093/ndt/gfi015. Epub 2005 Jul 26.

No abstract available

Comment on

Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial.
Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Silva SR, et al. Nephron. 1994;67(3):270-3. doi: 10.1159/000187978. Nephron. 1994. PMID: 7936015 Clinical Trial.
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia.
Harris E, Behrens J, Samson D, Rahemtulla A, Russell NH, Byrne JL. Harris E, et al. Br J Haematol. 2003 Jul;122(1):160-1. doi: 10.1046/j.1365-2141.2003.04395_2.x. Br J Haematol. 2003. PMID: 12823359 No abstract available.
Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis.
Hayashi T, Yamaguchi I, Saitoh H, Takagi M, Nonaka Y, Nomura T. Hayashi T, et al. Intern Med. 2003 Jul;42(7):605-8. doi: 10.2169/internalmedicine.42.605. Intern Med. 2003. PMID: 12879955